Vectura Share Discussion Threads

[diesel] 09/11/2017 10:11

POB, done the same this morning, added another small tranche, cash, patents, devices, in market products and pipeline must be worth 100, perhaps this is the final capitulation.

[a1ord53] 09/11/2017 09:44

Like I mentioned above imo every bad news even old one being used by shortsellers to sell down , cause they have to cover and need lower price to be able to cover millions if shares they short sold.
I will be not surprised that major shareholders of Vectura and BTG will look to see if both company should be merge.

[0815exitstrategy] 09/11/2017 09:27

I really don't get it why advair is now priced in multiple times?

[cityfarmer] 09/11/2017 09:25

Have also added today although extremely frustrating we are not a one trick pony and have a number of very valuable products on the market...

[a1ord53] 09/11/2017 09:23

Shore Capital reiterates BUY

Anybody has Numis and JPMorgan recommendations explanations why BUY ?

[pooroldboy55] 09/11/2017 09:19

Just bought 3000 more yes its a gamble but that's the name of the game I may not have got bottom but I think near anough.

[a1ord53] 09/11/2017 09:16

Extremely depressed sentiment supported by shortsellers .
I dont think that investors selling at this level - it is still potential without advair go to 140p
Advair doesnt worth 1£ in my opinion, which share price lost .

[citytrader66] 09/11/2017 09:11

i'm holding. i only got back in 2 days ago! paid c.95p

hoping its already priced in!

88/89p seems to be holding nicely.

[diesel] 09/11/2017 09:05

The value of this generic has been lost several times over since the first news of problems, this price fall is more to do with confidence, lack of, in management. Sold half my holding last year in the 140's should have sold the lot, keep thinking this can't get lower, oh well!

[letsmakesome] 09/11/2017 08:58

Class action is required I reckon. This has been in a downward spiral post the merger!

[davr0s] 09/11/2017 08:39

Shares making multi year lows are more likely to go further down - good luck with calling the bottom atm. Not for me

[pooroldboy55] 09/11/2017 08:38

If this is the bottom, big if may well buy some very big IF.

[davr0s] 09/11/2017 08:29

This shares been such an accident since the merger news. I doubled on the way up and thankfully sold 140ish if I recall last year. Not been tempted back in since.

[chop55] 09/11/2017 08:28

This is now the time to buy. Everybody knew that the Advair generic was no longer prized in. But the remaining portfolio has not lost it's value. And there is still a good chance to get the HIKMA advair generic approved 2018/19. It is already on the market in Europe with Sandoz......

[dunderheed] 09/11/2017 08:25

Yes you'd have thought the 'super-duper' skp 'management' might have identified this as a risk prior to merging?!

[pooroldboy55] 09/11/2017 08:21

Well somebody knew this was coming re the price fall over the last few weeks.

[alexchry] 09/11/2017 08:19

Problems getting approval in the USA hammered SKP years ago and it took quite a while to recover. I never realised just what importance the market put on Advair, Hikma's share price has halved and VEC's is not far behind.

[richtea2517] 09/11/2017 08:13

I bought a few today. Ever the optimist. I'm in no rush.

[a1ord53] 09/11/2017 08:12

It looks like advair is only one medication in portfolio and all others not exist . 20p cash - so value for all products is 65 p ?
Where are the analysts with their explanations of target prices 160p to 200 p ?

[rathean] 09/11/2017 08:05

I've had these on my watch list for so long I've forgotten why I thought they had potential. Chart looks bad, RNSs negative, is there any hope here at all?

[saxula] 09/11/2017 07:56

Vague as usual, but at least there's a time line towards being told it'll be another 18 months of retrials and FDA reviews, costing $$$m. GSK has this one nicely tied up

[gersemi] 09/11/2017 07:20

Come back SKP, all is forgiven

[alexchry] 09/11/2017 07:19

Now we know why the Hikma and VEC SP's have been so weak recently. Not sure whether this news is fully priced in or whether we've further the fall.

[rogerrail] 07/11/2017 13:08

pob

recent director buys should say enough about their position on the share price fall


alex

be that as it may , fluti represents 50% of revenue with potential new drivers ( China, k-haler) coming on stream.

[a1ord53] 07/11/2017 10:47

If anybody has information on what based target prices/ buy recommendations of all these so called guru analysts ? please kindly share it .
I dont believe that even if advair will be approved , share price wil go to 150p or 200 p
So why these guys giving us these nonsence recommendation misleading investors ?